FDA warns 17 companies illegally selling products for Alzheimer’s, Parkinson’s
By
Lois A. Bowers
Feb 12, 2019
Seventeen companies are illegally selling a total of 58 products they say can prevent, treat or cure Alzheimer’s disease, Parkinson’s disease or other health conditions, the U.S. Food and Drug Administration...
Recommendations to reduce disparities in dementia care due in 2021
By
Kimberly Bonvissuto
Dec 09, 2020
Final recommendations on ways to reduce disparities in dementia, which were developed during a stakeholder roundtable sponsored by the Milken Institute Alliance to Improve Dementia Care, will be released...
Are you ready for an Alzheimer’s breakthrough?
By
Lois A. Bowers
Nov 20, 2017
Some treatments for Alzheimer’s may be available by 2020. If so, the U.S. healthcare system may not be prepared, according to a new study.
Smartphones: ‘digital dementia’ contributor or cognitive memory aid?
By
Kimberly Bonvissuto
May 04, 2022
Smartphones: friend or foe? It depends on whom you ask. Recent studies on smartphone use have found that mobile technology either can contribute to cognitive impairment or help improve cognition.
One new law requires operators to provide tech for residents; another supports access to dementia screening...
By
Kimberly Bonvissuto
Oct 07, 2021
Assisted living operators in California will be required to provide video conferencing devices for residents under legislation signed into law on Monday. Another new law provides older adults in the Golden...
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
Alzheimer’s Association: Cognitive assessments lacking, but caregivers can help
By
Lois A. Bowers
Mar 06, 2019
Only 28% of older adults have ever been assessed for cognitive problems, and only 16% undergo routine cognitive assessments during routine health checkups, according to a report released Tuesday by the...
COVID-19 prevention efforts reduced mortality among residents with dementia
By
Kimberly Bonvissuto
Aug 29, 2023
After increasing “substantially” during the first year of the COVID-19 pandemic, dementia-related deaths declined in the second year, likely due to vaccination and prevention efforts in long-term care...
Focus on briefs: Dementia
Feb 01, 2023
Alzheimer’s blood test, Aducanumab approval issues, Medicare coverage of brain scans that diagnose dementia, Some at higher risk for Alzheimer’s
Lumosity to pay $2 million to settle deceptive advertising charges
By
Lois A. Bowers
Jan 07, 2016
Lumosity has agreed to pay $2 million to settle Federal Trade Commission charges that it deceived consumers with unfounded claims that its “brain games” can reduce or delay cognitive impairment...